STAT+: Why the WakeMed – Atrium Health hospital merger matters

STAT PlusNewsletterHealth Care Inc. Newsletter Why the WakeMed – Atrium Health hospital merger matters You’re reading STAT’s Health Care Inc. newsletter Manage alerts for this article Email this article Share this article By Bob HermanMay 18, 2026 Business of Health Care Reporter Bob Herman[email protected]Bob covers the money in health care, focusing on health insurance and hospitals.

His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc. newsletter.

You can reach Bob on Signal at bobjherman.09. This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Thanks for being here! So much to read, including a new series from my colleagues Lev Facher and Isa Cueto. They delved into the perils of alcohol despite its ubiquity in American culture.

The opening piece has several passages and quotes that will make you stop and think in a gratifying, educational way. Give it a read, and as always, pour your thoughts and tips my way: [email protected].Advertisement Wide a-Wake(Med) Most of you reading this do not live in North Carolina. But a hospital system merger in that state that has created local rage has national relevance.

STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account?

Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+.

Subscribe Log In drug development, government agencies, health care costs, hospitals, insurance, legal, Policy, STAT+ Submit a correction requestReprints Bob Herman Business of Health Care Reporter Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc.

newsletter. You can reach Bob on Signal at bobjherman.09. Newsletter Unpacking the business — and secretive inner workings — of the U.S.

health care industry Recommended The Readout May 18, 2026 STAT Plus: AstraZeneca picks up FDA approval for hypertension drug The Readout May 15, 2026 STAT Plus: A political contest in the U.K. could shake up drug pricing Advertisement Exclusive May 15, 2026 STAT Plus: Top U.S. officials pressured Germany to pay more for prescription drugs D.C.

Diagnosis May 14, 2026 STAT Plus: The hunt for FDA’s next leader The Readout May 14, 2026 STAT Plus: BeOne wins FDA approval in lymphoma race Subscriber Picks